Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reliability of Taste-Based Test for Lidocaine Effectiveness
NCT03680885Phase 1Completed
- Sponsor
- PhenoSolve
- Start
- Aug 2019
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of lidocaine 10% oropharyngeal spray in pain (2 arms), sponsored by PhenoSolve. Primary endpoints: Taste sensation after lidocaine or placebo and Ability to feel pressure and discomfort after injection of lidocaine. Started Aug 2019; status: completed.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
pain
Beyond the preview
Go deeper on NCT03680885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03680885.